Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
Healthcare
$18.31 +0.58%
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
52W Low $14.85High $23.00
Volume 0.68M
Average 0.41M
SPTX Total Debt
Short-term and long-term borrowings combined.
No reported Total Debt figures are available to summarize.
Total Debt history
Currency unavailable · from the balance sheet
No Total Debt data reported for this period type.
Total Debt vs competitors
How SPTX compares with its peers on the latest reported figures
SPTX Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $13.07M USD | +11.3% | +4.2% | 3.0% | |
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | $10.8M USD | +37.8% | +3.2% | 2.2% |
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | $6.95M USD | +15.9% | +12.1% | 2.7% |
| Mar 2026 | $5.59M USD | -12.6% | -2.6% | 1.3% | |
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | $3.47M USD | -7.7% | -47.1% | 0.9% |
| Mar 2026 | $432K USD | -34.3% | — | 0.2% | |
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | $410K USD | -56.3% | -61.6% | 0.3% |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | -7.7% | +0.3% | 1.3% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.